News
Financial Highlights for the Second Quarter Ended June 30, 2025 The Company’s interim condensed consolidated financial statements for the quarter and six months ended June 30, 2025, are prepared in ...
DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique au stade clinique (la « Société »), a annoncé aujourd'hui que son Rapport Financier Semestriel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback